title: Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1.
abstract: Recent epidemiologic studies have shown that abdominal obesity, characterized by a high waist to hip circumference ratio (WHR), is associated with increased cardiovascular morbidity and mortality. The present study examines components of the fibrinolytic system in obese and lean middle-aged women with a high and low WHR. Ten women in each group were carefully matched with respect to age, body weight, lean body mass, and body fat. Fibrinogen and endothelial type of plasminogen activator inhibitor -1 (PAI-1) were significantly elevated in the obese women with a high WHR compared with the obese women with a low WHR or with both groups of lean women. In addition, obese women with a high WHR exhibited a greater metabolic risk profile (elevated glucose, insulin, and triglyceride levels). When all subjects were pooled for the analyses, both fibrinogen and PAI-1 levels correlated positively with glucose and insulin levels. PAI-1 was also negatively related to degree of insulin sensitivity measured with the euglycemic clamp technique. In the obese groups, WHR but not body mass index (BMI), correlated with PAI-1 levels. No such correlations were seen in the lean groups. In conclusion, the data show that a high WHR in obese, but not lean middle-aged women, is associated with an impaired fibrinolytic activity. This perturbation becomes enhanced when it is associated with hyperinsulinemia and insulin resistance, which is a typical feature of abdominal obesity.
authors.affiliation: Department of Medicine II, University of Göteborg, Sahlgren's Hospital, Sweden.
authors.forename: K
authors.initials: K
authors.lastname: Landin
authors.forename: L
authors.initials: L
authors.lastname: Stigendal
authors.forename: E
authors.initials: E
authors.lastname: Eriksson
authors.forename: M
authors.initials: M
authors.lastname: Krotkiewski
authors.forename: B
authors.initials: B
authors.lastname: Risberg
authors.forename: L
authors.initials: L
authors.lastname: Tengborn
authors.forename: U
authors.initials: U
authors.lastname: Smith
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology; D005342:Fibrinolysis; D006801:Humans; D007328:Insulin / Q000097:blood; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000097:blood*; D015849:Plasminogen Inactivators / Q000097:blood*; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood
chemical_list: D007328:Insulin; D015849:Plasminogen Inactivators; D014280:Triglycerides